From wearing pink to correctly identifying the ribbon, breast cancer has an ingrained cultural presence. Both the color pink and the cancer ribbon are also reminders of just how common the disease is: ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. CHICAGO — Ribociclib extended PFS among patients with ...

Drug targets often focus on one thing, inhibiting or activating some critical function in a cell. Cancer drugs are no different, usually targeting things like cell termination, immune cell activation, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SAN ANTONIO — Longer duration of cyclin-dependent kinase ...

Despite differences in tumors, the addition of CDK 4/6 inhibitors to endocrine therapy showed a benefit in patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer ...

A class of drugs that inhibits breast cancer progression when used with hormonal therapy might also boost the effectiveness of immune therapy in cases of recurrent, metastatic breast cancer, according ...

While Pfizer’s experimental breast cancer drug palbociclib dominated the lead-in to the week, Eli Lilly, which also presented data at the American Association for Cancer Research meeting in San Diego, ...

Amongst the most common targets of anti-cancer drugs are small regulatory molecules called cyclin-dependent kinases (CDKs). In humans, several of these proteins regulate the cell cycle, a critical ...

As CDK 4/6 inhibitors become a bigger part of the treatment of breast cancer, CURE® sat down with clinical nurse specialist Patricia Jakel to discuss the essentials about the drug. CDK 4/6 inhibitors ...